NCT04086290View on ClinicalTrials.gov

National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 10, 2019

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2028

Conditions
Prostate Cancer Metastatic
Interventions
PROCEDURE

RARP

Radical prostatectomy + extended pelvic lymph node dissection

RADIATION

SBRT

Stereotactic body radiotherapy to osseous lesions

DRUG

ADT

six month of neo-adjuvant/concomitant medical castration therapy using a gonadotropin-releasing hormone antagonist or agonist.

Trial Locations (1)

2730

RECRUITING

Herlev and Gentofte Hospital, Herlev

All Listed Sponsors
lead

Peter Busch Østergren

OTHER

NCT04086290 - National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients | Biotech Hunter | Biotech Hunter